Target intelligence / Profile preview

RNA, U6 small nuclear 236, pseudogene (RNU6-236P)

Target
RNU6-236P
Molecular classification
Other, Small nuclear RNA pseudogene, Non-coding RNA (pseudogene)
01

Overview

**RNU6-236P** (RNA, U6 small nuclear 236, pseudogene) is a **pseudogene** derived from the U6 small nuclear RNA (snRNA) gene[4][5]. U6 snRNA is a core component of the spliceosome, catalyzing pre-mRNA splicing in the nucleus of eukaryotic cells[1]. However, **RNU6-236P is a non-functional copy** (“pseudogene”) and does not encode a functional snRNA or protein product[3][4][5]. Like other U6 pseudogenes, it may arise from retrotransposition events in the genome[3][5]. Pseudogenes, including those derived from U6 snRNA, generally **lack canonical biological functions** but may, in rare cases, be transcribed and could exert regulatory effects at the RNA level (e.g., acting as RNA decoys or influencing epigenetic regulation); however, there is **no evidence that RNU6-236P is involved in disease or has regulatory roles**[2][4]. It is not considered a therapeutic target, receptor, enzyme, or drug target, and there are **no drugs, biomarkers, or documented safety concerns** associated with this pseudogene[4]. In summary, **RNU6-236P is a genomic remnant of U6 snRNA with no known functional or therapeutic significance**.

Other names
RNU6-236PRNA, U6 small nuclear 236, pseudogene
02

Mechanism of action

None

03

Biological functions

No known canonical function as a pseudogene
04

Disease associations

No specific disease role identified for RNU6-236P

Beyond the preview

Go deeper on RNA, U6 small nuclear 236, pseudogene (RNU6-236P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 236, pseudogene (RNU6-236P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call